Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Ann Neurol. 2020 Jul 27;88(3):513–525. doi: 10.1002/ana.25826

TABLE 2.

Descriptive Data on Insulin Signaling and Related Measures

Median (interquartile range)
Variable n Total Diabetes Nondiabetes Pairwise Difference Mean (95% CI)
ELISA
 pS307IRS1 150 0.10 (0.09, 0.10) 0.10 (0.09, 0.10) 0.10 (0.09, 0.10)
 Total IRS1 150 0.28 (0.19, 0.40) 0.26 (0.17, 0.40) 0.33 (0.21, 0.44)
 pT308AKT1 150 0.15 (0.13, 0.18) 0.15 (0.13, 0.18) 0.15 (0.13, 0.18)
 Total AKT1 150 0.40 (0.20, 0.71) 0.36 (0.20, 0.64) 0.43 (0.23, 0.85)
 pS307IRS1/total IRS1a 150 0.34 (0.24, 0.49) 0.39 (0.26, 0.53) 0.31 (0.23, 0.46) 0.05 (0.01, 0.09)
 pT308AKT1/total AKT1a 150 0.41 (0.23, 0.65) 0.42 (0.24, 0.68) 0.36 (0.20, 0.60) 0.05 (−0.04, 0.14)
Immunohistochemistry
 IRS1 cells/mm2 139 5.72 (4.50, 7.29) 5.90 (4.64, 7.98) 5.30 (4.50, 6.91) −0.8 (−2.63, 1.02)
Ex vivo stimulation
 IRS1 recruitment to IRβ 78 4.66 (4.27, 5.10) 4.69 (4.33, 5.12) 4.55 (4.04, 5.10) 0.19 (−0.13, 0.51)
 pS473AKT1 78 4.45 (4.08, 4.81) 4.67 (4.22, 4.93) 4.35 (4.00, 4.69) 0.24 (0.01, 0.46)
 pT308AKT1 78 4.5 (4.09, 4.92) 4.55 (4.16, 4.99) 4.46 (3.87, 4.80) 0.26 (0.04, 0.48)
 pY1150/1151IRβ 78 4.67 (4.21, 5.24) 4.64 (4.27, 5.26) 4.68 (4.11, 5.24) 0.12 (−0.19, 0.44)
 pY960IRβ 78 4.53 (4.11, 4.97) 4.64 (4.11, 5.33) 4.42 (4.10, 4.88) 0.18 (−0.11, 0.46)
a

Among the ELISA measures, the ratios were the primary variables of interest.

CI = confidence interval; ELISA = enzyme-linked immunosorbent assay.